Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Radiation Injuries 1Mixed Tumor, Mesodermal 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Breast Neoplasms 1

Interventions

Gemcitabine 9Cisplatin 9pembrolizumab 5durvalumab 3Specimen Handling 3Platinum 3Oxaliplatin 3Leucovorin 31,2-diaminocyclohexaneplatinum II citrate 3Taxes 2Nivolumab 2Magnetic Resonance Spectroscopy 2Folfox protocol 2Fluorouracil 2Biopsy 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zanidatamab 1trastuzumab deruxtecan 1peposertib 1dehydroftorafur 1binimetinib 1avelumab 1Trastuzumab 1Tegafur 1S 1 (combination) 1Radiation Dose Hypofractionation 1Radiation 1Paclitaxel 1Lymph Node Excision 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Neoplasms × Lymph Node Excision × 90 days × Clear all
NCT04559139 2026-05-01

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Eastern Cooperative Oncology Group

Phase 2/3 Active not recruiting
186 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡